Home / Inspections / 1231283

FDA Inspection 1231283 — Vitalant (Harmar - Fox Chapel Area)

Vitalant (Harmar - Fox Chapel Area) — FEI 2529059

The FDA completed an inspection of Vitalant (Harmar - Fox Chapel Area) on February 23, 2024 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 23, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pittsburgh, PA (United States)

Facility

Other inspections at this facility

  • 1107088 (NAI Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1024632 (NAI Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 933477 (NAI Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 838122 (NAI Fri Jun 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 751770 (NAI Fri Oct 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources